The table below shows Tarsus Pharmaceuticals, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$451.36M
$182.95M
$17.45M
$25.82M
$57.03M
$0.00
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$64.32M
$53.39M
$50.31M
$42.62M
$41.71M
$18.83M
SG&A
$427.32M
TARS annual revenue (10-K history)
Tarsus Pharmaceuticals, Inc. reported annual revenue of $451.36M for fiscal year 2025. That is up 146.7% from $182.95M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.